Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-12-04An Open Label, Multicentre, Two Stage, Phase II Study To Evaluate Efficacy And Safety Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
-
CLINICAL_TRIALS study record update · 2012-11-05Phase II Study of Metastatic Melanoma Using a Chemoradiation Lymphodepleting Conditioning Regimen Followed by Infusion of Anti-Mart-1 and Anti-gp100 TCR-Gene Engineered Lymphocytes and Peptide Vaccines
-
CLINICAL_TRIALS study record update · 2012-10-30A Randomized Phase II Study of Oral Lenalidomide (Revlimid [TM]), an Antiangiogenic and Immunomodulatory Agent, in Subjects With Stage IV Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2012-10-10Phase I/II Study of Therapeutic Vaccination With Escalating Doses of Theravac®, a Proteinic Vector Targeting Dendritic Cells Coupled to a Melanoma Antigen, in Patients With Advanced Metastatic Melanoma.
-
CLINICAL_TRIALS study record update · 2012-10-03In Vivo Reflectance Confocal Microscopy for Pigmented Lesion Diagnosis: A Multi-center Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-03ClinicalTrials.gov study NCT01677975
-
CLINICAL_TRIALS study record update · 2012-08-22Can We Miss Pigmented Lesions in Psoriasis Patients?
-
CLINICAL_TRIALS study record update · 2012-08-20A Phase II Study of Isolated Hepatic Perfusion (IHP) With Melphalan Followed by Temozolomide for Subjects With Unresectable Hepatic Metastases From Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2012-08-15A Phase I Study of MK-4827 in Combination With Temozolomide in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2012-08-14Randomized Comparison of Peptide Immunization in Patients at High Risk for Recurrence of Melanoma
-
CLINICAL_TRIALS study record update · 2012-08-03(Inhibition of NF-kB Signaling in Melanoma Therapy) A Phase I/II Clinical Trial of PS-341, a Proteasome Inhibitor, in Combination With an Extended Continuous Oral Schedule of Temozolomide in Patients With Advanced Refractory Solid Tumors With the Phase II Component Only in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2012-08-02A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Superficial Groin Dissection in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-02A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-14Phase II Study in Metastatic Melanoma Using Lymphocytes Reactive With the gp100 Antigen and Immunization Using a Recombinant rF-gp100P209 Virus Encoding a gp100 Peptide Following a Nonmyeloablative Lymphocyte Depleting Regimen
-
CLINICAL_TRIALS study record update · 2012-06-08Phase I/II Study of Haploidentical Natural Killer Cell Infusion in Patients With Refractory or Relapsed Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-07A Phase II, Multicenter, Open-Label Study of YM155 in Subjects With Unresectable Stage III or Metastatic (Stage IV) Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-07Phase I/II Study Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Allogeneic Tumor-Reactive Lymphocyte Cell Line DMF5 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-06An Open Label, Randomized Clinical Comparability Study Of The Current Liquid And Commercial Liquid Formulations
-
CLINICAL_TRIALS study record update · 2012-06-06A Phase 1, Open Label, Single Arm Study To Establish The Safety Of Administering CP 675,206 As A One Hour Infusion In Patients With Surgically Incurable Stage III Or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2012-05-04Evaluation of Two Different Schedules of Palonosetron for the Prevention of Nausea and Vomiting in Patients With Metastatic Melanoma Receiving Concurrent Biochemotherapy
-
CLINICAL_TRIALS study record update · 2012-04-25An Open-Label Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 as Therapy in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2012-04-19A Phase II Trial of Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
-
CLINICAL_TRIALS study record update · 2012-04-18Biochemotherapy With Temozolomide, Velban, Cisplatin, Interleukin-2, Interferon-alpha and Thalidomide for Metastatic Melanoma With Optional Intrathecal Interleukin-2 Treatment
-
CLINICAL_TRIALS study record update · 2012-04-11A Phase I Open-label Study of the Safety and Immunogenicity of Escalating Doses of Lipovaxin-MM, a Novel Melanoma Immunotherapeutic, in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-04-04A Prospective Phase II Study of Radiation Therapy and Concurrent Cisplatin Chemotherapy in the Treatment of Locally Advanced or Metastatic Malignant Melanoma